Hospice care for end stage liver disease in the United States

References

• Centers for disease control and prevention, national center for health statistics. Underlying cause of death 1999–2017 on CDC wonder online database [internet]. [ cited 2020 Sep 3]. Available from: http://wonder.cdc.gov/ucd-icd10.html.
   Google Scholar
• Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–178.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Wade JB, Gibson DP, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106(9):1646–1653.
   PubMed Web of Science ®Google Scholar
• Samoylova ML, Covinsky KE, Haftek M, et al. Disability in patients with end-stage liver disease: results from the functional assessment in liver transplantation study. Liver Transpl. 2017;23(3):292–298.
   PubMed Web of Science ®Google Scholar
• Orman ES, Ghabril M, Emmett TW, et al. Hospital readmissions in patients with cirrhosis: a systematic review. J Hosp Med. 2018;13:490–495.
   Web of Science ®Google Scholar
• Stepanova M, De Avila L, Afendy M, et al. Direct and indirect economic burden of chronic liver disease in the United States. Clin Gastroenterol Hepatol. 2017;15(759–766):e5.
   PubMedGoogle Scholar
• Lupu D, Quigley L, Mehfoud N, et al. The growing demand for hospice and palliative medicine physicians: will the supply keep up? J Pain Symptom Manag. 2018;55(4):1216–1223.
   PubMed Web of Science ®Google Scholar
• Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.
   PubMed Web of Science ®Google Scholar
• Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. Jama. 2009;302(7):741–749.
   PubMed Web of Science ®Google Scholar
• Kavalieratos D, Corbelli J, Zhang D, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. Jama. 2016;316(20):2104–2114.
   PubMed Web of Science ®Google Scholar
• Mazzarelli C, Prentice WM, Heneghan MA, et al. Palliative care in end-stage liver disease: time to do better? Liver Transplant. 2018;24(7):961–968.
   PubMed Web of Science ®Google Scholar
• Low JTS, Rohde G, Pittordou K, et al. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69(6):1260–1273.
   PubMed Web of Science ®Google Scholar
• Rush B, Walley KR, Celi LA, et al. Palliative care access for hospitalized patients with end-stage liver disease across the United States. Hepatology. 2017;66(5):1585–1591.
   PubMed Web of Science ®Google Scholar
• Verma M, Kosinski AS, Volk ML, et al. Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial. J Palliat Med. 2019;22(S1):34–43.
   PubMedGoogle Scholar
• Centers for medicare & medicaid services. Local coverage determination (LCD): hospice-determining terminal status (l33393) [internet]. Baltimore, MD; 2019 [ cited 2020 Sep 3]. Available from: https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=33393&ver=5&CntrctrSelected=272*1&Cntrctr=272&name=National+Government+Services%2C+Inc.+(06004%2C+HHH+MAC)&DocType=All&s=56&bc=AggAAAIAgAAA&.
   Google Scholar
• Langberg KM, Kapo JM, Taddei TH. Palliative care in decompensated cirrhosis: a review. Liver Int. 2018;38(5):768–775.
   PubMed Web of Science ®Google Scholar
• Tandon P, Walling A, Patton H, et al. AGA clinical practice update on palliative care management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2020; DOI:10.1016/j.cgh.2020.11.027
   Web of Science ®Google Scholar
• Peng JK, Hepgul N, Higginson IJ, et al. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med. 2019;33(1):24–36.
   PubMed Web of Science ®Google Scholar
• De Ledinghen V, Heresbach D, Fourdan O, et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut. 1999;44(2):270–273.
   PubMed Web of Science ®Google Scholar
• Wong F, Massie D, Hsu P, et al. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology. 1993;104(3):869–876.
   PubMed Web of Science ®Google Scholar
• Moon AM, Jiang Y, Rogal SS, et al. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis. Aliment Pharmacol Ther. 2020;51(6):652–660.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Boparai N, Price LL, et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96(7):2199–2205.
   PubMed Web of Science ®Google Scholar
• Rakoski MO, McCammon RJ, Piette JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012;55(1):184–191.
   PubMed Web of Science ®Google Scholar
• Chatrath H, Liangpunsakul S, Ghabril M, et al. Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med. 2012;125(10):1019–1025.
   PubMed Web of Science ®Google Scholar
• Poonja Z, Brisebois A, S V VZ, et al. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol. 2014;12(4):692–698.
   PubMed Web of Science ®Google Scholar
• Bunchorntavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis. 2012;16(2):331–346.
   PubMed Web of Science ®Google Scholar
• Russ TC, Kivimaki M, Morling JR, et al. Association between psychological distress and liver disease mortality: a meta-analysis of individual study participants. Gastroenterology. 2015;148(958–966):e4.
   PubMedGoogle Scholar
• Scaglione S, Kliethermes S, Cao G, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49(8):690–696.
   PubMed Web of Science ®Google Scholar
• Cheng Y-W, Sandrasegaran K, Cheng K, et al. A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis. Abdom Radiol (New York). 2018;43(8):2190–2197.
   PubMed Web of Science ®Google Scholar
• Macken L, Bremner S, Gage H, et al. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Aliment Pharmacol Ther. 2020;52(1):107–122.
   PubMed Web of Science ®Google Scholar
• Cooper M, Pollard A, Pandey A, et al. palliative long-term abdominal drains versus large volume paracentesis in refractory ascites due to cirrhosis (reduce study): qualitative outcomes. J Pain Symptom Manage. 2020. 10.1016/j.jpainsymman.2020.12.007
   Google Scholar
• Caldwell J, Edriss H, Nugent K. Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites. Proc (Bayl Univ Med Cent). 2018;31(3):297–302.
   PubMedGoogle Scholar
• Casadaban LC, Parvinian A, Couture PM, et al. Characterization of liver function parameter alterations after transjugular intrahepatic portosystemic shunt creation and association with early mortality. Am J Roentgenol. 2014;203(6):1363–1370.
   PubMed Web of Science ®Google Scholar
• Riggio O, Nardelli S, Moscucci F, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2012;16(1):133–146.
   PubMed Web of Science ®Google Scholar
• Sharma BC, Sharma P, Agrawal A, et al. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology. 2009;137(885–891):891.e1.
   Google Scholar
• Buganza-Torio E, Mitchell N, Abraldes JG, et al. Depression in cirrhosis – a prospective evaluation of the prevalence, predictors and development of a screening nomogram. Aliment Pharmacol Ther. 2019;49(2):194–201.
   PubMed Web of Science ®Google Scholar
• Singh GK, Hoyert DL. Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption. Hum Biol. 2000;72(5):801–820.
   PubMed Web of Science ®Google Scholar
• Puchalski C, Ferrell B, Virani R, et al. Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med. 2009;12(10):885–904.
   PubMed Web of Science ®Google Scholar
• Nguyen DL, Chao D, Ma G, et al. Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients. Ann Gastroenterol. 2015;28(1):124–129.
   PubMed Web of Science ®Google Scholar
• Kunzler-Heule P, Beckmann S, Mahrer-Imhof R, et al. Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study. J Clin Nurs. 2016;25(17–18):2559–2568.
   PubMed Web of Science ®Google Scholar
• Hareendran A, Devadas K, Sreesh S, et al. Quality of life, caregiver burden and mental health disorders in primary caregivers of patients with Cirrhosis. Liver Int Off J Int Assoc Study Liver. 2020;40(12):2939-2949.
   Google Scholar
• Fabrellas N, Moreira R, Carol M, et al. Psychological burden of hepatic encephalopathy on patients and caregivers. Clin Transl Gastroenterol. 2020;11(4):e00159.
   PubMedGoogle Scholar
• Hansen L, Chang MF, Lee CS, et al. Physical and mental quality of life in patients with end-stage liver disease and their informal caregivers. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021;19(155–161):e1.
   PubMedGoogle Scholar
• Donlan J, Ufere NN, Indriolo T, et al. Patient and caregiver perspectives on palliative care in end-stage liver disease. J Palliat Med. 2020; 10.1089/jpm.2020.0551
   PubMed Web of Science ®Google Scholar
• Stroebe M, Schut H, Stroebe W. Health outcomes of bereavement. Lancet. 2007;370(9603):1960–1973.
   PubMed Web of Science ®Google Scholar
• Johnson KS, Kuchibhatla M, Tanis D, et al. Racial differences in hospice revocation to pursue aggressive care. Arch Intern Med. 2008;168(2):218–224.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470.
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96.
   PubMed Web of Science ®Google Scholar
• Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40(6):897–903.
   PubMed Web of Science ®Google Scholar
• Nagai S, Chau LC, Schilke RE, et al. Effects of allocating livers for transplantation based on model for end-stage liver disease-sodium scores on patient outcomes. Gastroenterology. 2018;155(1451–1462):e3.
   Google Scholar
• Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018–1026.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649.
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology. 1987;7(4):660–664.
   PubMed Web of Science ®Google Scholar
• Mishra P, Desai N, Alexander J, et al. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience. J Gastroenterol Hepatol. 2007;22(8):1232–1235.
   PubMed Web of Science ®Google Scholar
• Hernaez R, Solà E, Moreau R, et al. Acute-on-chronic liver failure: an update. Gut. 2017;66(3):541–553.
   PubMed Web of Science ®Google Scholar
• Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038–1047.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, O’Leary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60(1):250–256.
   PubMed Web of Science ®Google Scholar
• Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol. 1993;88(4):514–519.
   PubMed Web of Science ®Google Scholar
• Salerno F, Cammà C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology. 2007;133(3):825–834.
   PubMed Web of Science ®Google Scholar
• Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279–1290.
   PubMed Web of Science ®Google Scholar
• Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the international club of ascites. J Hepatol. 2015;62(4):968–974.
   PubMed Web of Science ®Google Scholar
• Fede G, D’Amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol. 2012;56(4):810–818.
   PubMed Web of Science ®Google Scholar
• Fallon MB, Krowka MJ, Brown RS, et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008;135(4):1168–1175.
   PubMed Web of Science ®Google Scholar
• Schenk P, Schoniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125(4):1042–1052.
   PubMed Web of Science ®Google Scholar
• Martin P, DiMartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144–1165.
   PubMed Web of Science ®Google Scholar
• Lai JC, Sonnenday CJ, Tapper EB, et al. Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant. 2019;19(7):1896–1906.
   PubMed Web of Science ®Google Scholar
• Carey EJ, Steidley DE, Aqel BA, et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010;16(12):1373–1378.
   PubMed Web of Science ®Google Scholar
• Lai JC, Feng S, Terrault NA, et al. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014;14(8):1870–1879.
   PubMed Web of Science ®Google Scholar
• Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66(2):564–574.
   PubMed Web of Science ®Google Scholar
• Orman ES, Ghabril M, Chalasani N. Poor performance status is associated with increased mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14(1189–1195):e1.
   PubMedGoogle Scholar
• Tapper EB, Finkelstein D, Mittleman MA, et al. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–590.
   PubMed Web of Science ®Google Scholar
• Lai JC, Rahimi RS, Verna EC, et al. Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study. Gastroenterology. 2019;156(6):1675–1682.
   PubMed Web of Science ®Google Scholar
• Tandon P, Reddy KR, O’Leary JG, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017;65(1):217–224.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423.
   PubMed Web of Science ®Google Scholar
• Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23(5):625–633.
   PubMed Web of Science ®Google Scholar
• Van Vugt JL, Levolger S, De Bruin RW, et al. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant. 2016;16(8):2277–2292.
   PubMed Web of Science ®Google Scholar
• Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60(6):1151–1157.
   PubMed Web of Science ®Google Scholar
• Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10(2):166–173, 173.e1.
   PubMed Web of Science ®Google Scholar
• Hudson BE, Ameneshoa K, Gopfert A, et al. Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention. Frontline Gastroenterol. 2017;8(1):45–52.
   PubMed Web of Science ®Google Scholar
• Highet G, Crawford D, Murray SA, et al. Development and evaluation of the Supportive and Palliative Care Indicators Tool (SPICT): a mixed-methods study. BMJ Support Palliat Care. 2014;4(3):285–290.
   PubMedGoogle Scholar
• Kia L, Cuttica MJ, Yang A, et al. The utility of pulmonary function testing in predicting outcomes following liver transplantation. Liver Transpl. 2016;22(6):805–811.
   PubMed Web of Science ®Google Scholar
• Pfitzmann R, Schwenzer J, Rayes N, et al. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 2007;13(2):197–205.
   PubMed Web of Science ®Google Scholar
• Bouscarat F, Samuel D, Simon F, et al. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis. 1994;19(5):854–859.
   PubMed Web of Science ®Google Scholar
• Organ procurement and transplantation network policies [internet]. 2020 [ cited 2020 May 16]. Available from: https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf.
   Google Scholar
• Keller EJ, Kwo PY, Helft PR. Ethical considerations surrounding survival benefit-based liver allocation. Liver Transpl. 2014;20(2):140–146.
   PubMed Web of Science ®Google Scholar
• Volk ML, Biggins SW, Huang MA, et al. Decision making in liver transplant selection committees: a multicenter study. Ann Intern Med. 2011;155(8):503–508.
   PubMed Web of Science ®Google Scholar
• Smilowitz NR, Gupta N, Ramakrishna H, et al. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol. 2017;2(2):181–187.
   PubMed Web of Science ®Google Scholar
• Plotkin JS, Scott VL, Pinna A, et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2(6):426–430.
   PubMedGoogle Scholar
• Maddur H, Bourdillon PD, Liangpunsakul S, et al. Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation. Liver Transpl. 2014;20(6):664–672.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Yotti R, Bermejo J, et al. The heart in liver transplantation. J Hepatol. 2011;54(4):810–822.
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transplant. 2000;6(4):443–450.
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Fallon MB, Kawut SM, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100(7):1440–1452.
   PubMed Web of Science ®Google Scholar
• Hollatz TJ, Musat A, Westphal S, et al. Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension. Liver Transpl. 2012;18(6):686–695.
   PubMed Web of Science ®Google Scholar
• Spengler EK, O’Leary JG, Te HS, et al. Liver transplantation in the obese cirrhotic patient. Transplantation. 2017;101(10):2288–2296.
   PubMed Web of Science ®Google Scholar
• Bambha KM, Dodge JL, Gralla J, et al. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: risk modulated by model for end-stage liver disease. Liver Transpl. 2015;21(10):1286–1294.
   PubMed Web of Science ®Google Scholar
• Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(10):897–901.
   PubMed Web of Science ®Google Scholar
• Zamora-Valdes D, Watt KD, Kellogg TA, et al. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatology. 2018;68(2):485–495.
   PubMed Web of Science ®Google Scholar
• Gomez Gavara C, Esposito F, Gurusamy K, et al. Liver transplantation in elderly patients: a systematic review and first meta-analysis. HPB. 2019;21(1):14–25.
   PubMed Web of Science ®Google Scholar
• Sundaram V, Lim J, Tholey DM, et al. The Braden Scale, A standard tool for assessing pressure ulcer risk, predicts early outcomes after liver transplantation. Liver Transpl. 2017;23(9):1153–1160.
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, Thuluvath AJ, Savva Y. Karnofsky performance status before and after liver transplantation predicts graft and patient survival. J Hepatol. 2018;69(4):818–825.
   PubMed Web of Science ®Google Scholar
• Tandon P, Goodman KJ, Ma MM, et al. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation. Am J Gastroenterol. 2009;104(7):1700–1706.
   PubMed Web of Science ®Google Scholar
• Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365(19):1790–1800.
   PubMed Web of Science ®Google Scholar
• Im GY, Kim-Schluger L, Shenoy A, et al. Early liver transplantation for severe alcoholic hepatitis in the United States – a single-center experience. Am J Transplant. 2016;16(3):841–849.
   PubMed Web of Science ®Google Scholar
• Laederach-Hofmann K, Bunzel B. Noncompliance in organ transplant recipients: a literature review. Gen Hosp Psychiatry. 2000;22(6):412–424.
   PubMed Web of Science ®Google Scholar
• Douglas S, Blixen C, Bartucci MR. Relationship between pretransplant noncompliance and posttransplant outcomes in renal transplant recipients. J Transpl Coord. 1996;6(2):53–58.
   PubMedGoogle Scholar
• Ladin K, Daniels A, Osani M, et al. Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transpl Rev. 2018;32(1):16–28.
   Web of Science ®Google Scholar
• Ladin K, Emerson J, Berry K, et al. Excluding patients from transplant due to social support: results from a national survey of transplant providers. Am J Transplant. 2019;19(1):193–203.
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–750.
   PubMed Web of Science ®Google Scholar
• Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005;128(3):620–626.
   PubMed Web of Science ®Google Scholar
• Sapisochin G, Fidelman N, Roberts JP, et al. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011;17(8):934–942.
   PubMed Web of Science ®Google Scholar
• Watt KD, Pedersen RA, Kremers WK, et al. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology. 2009;137(6):2010–2017.
   PubMed Web of Science ®Google Scholar
• Miao Y, Everly JJ, Gross TG, et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation. 2009;87(9):1347–1359.
   PubMed Web of Science ®Google Scholar
• Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transpl. 1997;2:14–17.
   PubMedGoogle Scholar
• Beauchamp TL, Childress JF. Principles of biomedical ethics. USA: Oxford University Press; 2001.
   Google Scholar
• McElroy LM, Daud A, Davis AE, et al. A meta-analysis of complications following deceased donor liver transplant. Am J Surg. 2014;208(4):605–618.
   PubMed Web of Science ®Google Scholar
• Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. Jama. 2004;291(1):88–93.
   PubMed Web of Science ®Google Scholar
• Wallston KA, Burger C, Smith RA, et al. Comparing the quality of death for hospice and non-hospice cancer patients. Med Care. 1988;26(2):177–182.
   PubMed Web of Science ®Google Scholar
• Wright AA, Keating NL, Balboni TA, et al. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol. 2010;28(29):4457–4464.
   PubMed Web of Science ®Google Scholar
• Obermeyer Z, Makar M, Abujaber S, et al. Association between the medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer. Jama. 2014;312:1888–1896.
   PubMed Web of Science ®Google Scholar
• Connor SR, Pyenson B, Fitch K, et al. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage. 2007;33(3):238–246.
   PubMed Web of Science ®Google Scholar
• Teno JM, Shu JE, Casarett D, et al. Timing of referral to hospice and quality of care: length of stay and bereaved family members’ perceptions of the timing of hospice referral. 2007;34:120–125.J Pain Symptom Manage
   PubMed Web of Science ®Google Scholar
• Gelfman LP, Barrón Y, Moore S, et al. Predictors of hospice enrollment for patients with advanced heart failure and effects on health care use. JACC Heart Fail. 2018;6(9):780–789.
   PubMed Web of Science ®Google Scholar
• Wachterman MW, Hailpern SM, Keating NL, et al. Association between hospice length of stay, health care utilization, and medicare costs at the end of life among patients who received maintenance hemodialysis. JAMA Intern Med. 2018;178(6):792–799.
   PubMed Web of Science ®Google Scholar
• Richards CA, Hebert PL, Liu C-F, et al. Association of family ratings of quality of end-of-life care with stopping dialysis treatment and receipt of hospice services. JAMA Network Open. 2019;2(10):e1913115.
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Chang HT, Hwang IH, et al. Hospice offers more palliative care but costs less than usual care for terminal geriatric hepatocellular carcinoma patients: a nationwide study. J Palliat Med. 2013;16(7):780–785.
   PubMed Web of Science ®Google Scholar
• Chiang JK, Kao YH. The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan. Support Care Cancer. 2015;23(4):1049–1055.
   PubMed Web of Science ®Google Scholar
• Sanoff HK, Chang Y, Reimers M, et al. Hospice utilization and its effect on acute care needs at the end of life in medicare beneficiaries with hepatocellular carcinoma. J Oncol Pr. 2017;13(3):e197–e206.
   PubMed Web of Science ®Google Scholar
• Fukui N, Golabi P, Otgonsuren M, et al. Hospice care in medicare patients with primary liver cancer: the impact on resource utilisation and mortality. Aliment Pharmacol Ther. 2018;47(5):680–688.
   PubMed Web of Science ®Google Scholar
• Holden JH, Shamseddeen H, Johnson AW, et al. Palliative care and hospice referrals in patients with decompensated cirrhosis: what factors are important? J Palliat Med. 23(8): 1066–1075. 2020.
   PubMed Web of Science ®Google Scholar
• Baumann AJ, Wheeler DS, James M, et al. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manag. 2015;50(882–886):e2.
   Google Scholar
• Altaii H, Al-Kindi SG, Yaqoob Z, et al. Place of death and hospice utilization among patients who die from cirrhosis in the United States. Clin Gastroenterol Hepatol. 2018;16(1):142–143.
   PubMed Web of Science ®Google Scholar
• Teno JM, Gozalo P, Trivedi AN, et al. Site of death, place of care, and health care transitions among US medicare beneficiaries, 2000-2015. J Am Med Assoc. 2018;320(3):264–271.
   Web of Science ®Google Scholar
• Ufere NN, Halford JL, Caldwell J, et al. Health care utilization and end-of-life care outcomes for patients with decompensated cirrhosis based on transplant candidacy. J Pain Symptom Manage. 2020;59(3)590–598.
   PubMed Web of Science ®Google Scholar
• Brown CL, Hammill BG, Qualls LG, et al. Significant morbidity and mortality among hospitalized end-stage liver disease patients in medicare. J Pain Symptom Manag. 2016;52(412–419):e1.
   PubMedGoogle Scholar
• Wright A, Letting KI. Go of the rope – aggressive treatment, hospice care, and open access. N Engl J Med. 2007;357(4):324–327.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, Egan PC, Olszewski AJ. Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood. 2018;132(7):717–726.
   PubMed Web of Science ®Google Scholar
• Yeung HN, Mitchell WM, Roeland EJ, et al. Palliative radiation before hospice: the long and the short of it. J Pain Symptom Manage. 2014;48(6):1070–1079.
   PubMed Web of Science ®Google Scholar
• Wright AA, Zhang B, Keating NL, et al. Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study. BMJ. 2014;348(mar04 4):1–10.
   Google Scholar
• Zama IN, Edgar M. Management of symptomatic ascites in hospice patients with paracentesis: a case series report. Am J Hosp Palliat Med. 2012;29(5):405–408.
   PubMed Web of Science ®Google Scholar
• Mor V, Wagner TH, Levy C, et al. Association of expanded va hospice care with aggressive care and cost for veterans with advanced lung cancer. JAMA Oncol. 2019;5(6):810–816.
   PubMed Web of Science ®Google Scholar
• Sheedy C, Christopher L, Booker C, et al. Evaluation of the medicare care choices model: annual report 2 [internet]. Rockville, MD; 2020. [cited 2020 Oct 10]. Available from: https://downloads.cms.gov/files/mccm-secannrpt.pdf.
   Google Scholar
• Medici V, Rossaro L, Wegelin JA, et al. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transplant. 14(8): 1100–1106. 2008.
   PubMed Web of Science ®Google Scholar
• Kimbell B, Boyd K, Kendall M, et al. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5(11):e009241.
   PubMed Web of Science ®Google Scholar
• Low J, Davis S, Vickerstaff V, et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open. 2017;7(8):e016887.
   PubMed Web of Science ®Google Scholar
• Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. Bmj. 2000;320(7233):469–472.
   PubMed Web of Science ®Google Scholar
• Vijeratnam SS, Candy B, Craig R, et al. Palliative care for patients with end-stage liver disease on the liver transplant waiting list: an international systematic review. Dig Dis Sci. 2021; 10.1007/s10620-020-06779-1
   PubMed Web of Science ®Google Scholar
• Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–1952.
   PubMed Web of Science ®Google Scholar
• Braun LT, Grady KL, Kutner JS, et al. palliative care and cardiovascular disease and stroke: a policy statement from the American Heart Association/American Stroke Association. Circulation. 2016;134(11):e198–e225.
   PubMed Web of Science ®Google Scholar
• Ferrell BR, Temel JS, Temin S, et al. Integration of Palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96–112.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Evans CJ, Grande G, et al. Evaluating complex interventions in end of life care: the morecare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews. BMC Med. 2013;11(1):111.
   PubMedGoogle Scholar
• Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70: 9 LP – 29.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:362.
   Google Scholar
• Dang K, Hirode G, Singal AK, et al. Alcoholic liver disease epidemiology in the United States: a retrospective analysis of 3 US databases. Am J Gastroenterol. 2020;115(1):96–104.
   PubMed Web of Science ®Google Scholar
• Vaughn-Sandler V, Sherman C, Aronsohn A, et al. Consequences of perceived stigma among patients with cirrhosis. Dig Dis Sci. 2014;59(3):681–686.
   PubMed Web of Science ®Google Scholar
• Stienstra D, Chochinov HM. Palliative care for vulnerable populations. Palliat Support Care. 2012;10(1):37–42.
   PubMed Web of Science ®Google Scholar
• Hudson B, Hunt V, Waylen A, et al. The incompatibility of healthcare services and end-of-life needs in advanced liver disease: a qualitative interview study of patients and bereaved carers. Palliat Med. 32(5): 908–918. 2018.
   PubMed Web of Science ®Google Scholar